Swedbank AB trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 3.1% during the fourth quarter, HoldingsChannel reports. The fund owned 1,726,000 shares of the company’s stock after selling 55,532 shares during the quarter. Swedbank AB’s holdings in Option Care Health were worth $54,990,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health during the fourth quarter worth about $25,000. Cornerstone Planning Group LLC increased its stake in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. McIlrath & Eck LLC acquired a new position in Option Care Health during the second quarter worth about $37,000. Advisory Services Network LLC acquired a new position in Option Care Health during the third quarter worth about $35,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health during the third quarter worth about $38,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Timothy P. Sullivan bought 24,154 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were purchased at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the transaction, the director owned 73,383 shares in the company, valued at $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO John Charles Rademacher bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the transaction, the chief executive officer owned 695,152 shares of the company’s stock, valued at $14,723,319.36. The trade was a 1.83% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 73,264 shares of company stock worth $1,548,316 over the last ninety days. 1.70% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Read Our Latest Analysis on OPCH
Option Care Health Price Performance
OPCH stock opened at $20.93 on Monday. The company’s 50 day simple moving average is $25.96 and its 200-day simple moving average is $30.05. The firm has a market capitalization of $3.29 billion, a PE ratio of 16.22, a P/E/G ratio of 1.16 and a beta of 0.68. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.
Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company’s quarterly revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities analysts expect that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.
About Option Care Health
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Featured Stories
- Five stocks we like better than Option Care Health
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
